Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations and dividends.
Earnings and Valuation
This table compares Nihon Kohden and Envoy Medical”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nihon Kohden | $1.48 billion | 1.15 | $93.05 million | $0.51 | 19.55 |
| Envoy Medical | $240,000.00 | 226.99 | -$23.76 million | ($1.22) | -0.58 |
Profitability
This table compares Nihon Kohden and Envoy Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nihon Kohden | 5.32% | 7.25% | 5.12% |
| Envoy Medical | -9,857.26% | N/A | -256.65% |
Analyst Ratings
This is a breakdown of recent recommendations for Nihon Kohden and Envoy Medical, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nihon Kohden | 0 | 0 | 0 | 1 | 4.00 |
| Envoy Medical | 1 | 1 | 2 | 0 | 2.25 |
Envoy Medical has a consensus price target of $6.00, indicating a potential upside of 746.74%. Given Envoy Medical’s higher possible upside, analysts clearly believe Envoy Medical is more favorable than Nihon Kohden.
Risk & Volatility
Nihon Kohden has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.07, meaning that its share price is 107% more volatile than the S&P 500.
Insider & Institutional Ownership
0.1% of Nihon Kohden shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 7.1% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Nihon Kohden beats Envoy Medical on 9 of the 15 factors compared between the two stocks.
About Nihon Kohden
Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.
About Envoy Medical
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.
